XML 36 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Cash flows from operating activities:      
Net income including noncontrolling interests in operating subsidiaries $ 59,289 $ 21,645 $ 37,016
Adjustments to reconcile net income including noncontrolling interests in operating subsidiaries to net cash provided by operating activities:      
Depreciation and amortization 39,168 9,850 7,017
Non-cash stock compensation 25,657 13,579 7,121
Change in valuation allowance (10,651) 0 0
Other 777 (15) (32)
Changes in assets and liabilities:      
Accounts receivable (6,928) 5,072 (2,877)
Prepaid expenses and other assets (1,294) 1,075 (757)
Accounts payable and accrued expenses / costs 3,039 (1,364) (1,414)
Royalties and contingent legal fees payable (11,000) 10,748 358
Deferred revenues 0 0 (1,510)
Deferred income tax 6,546 0 0
Net cash provided by operating activities 104,603 60,590 44,922
Cash flows from investing activities:      
Purchase of property and equipment (268) (190) (58)
Purchase of available-for-sale investments (402,500) (8,427) 0
Sale of available-for-sale investments 322,236 60 184
Purchase of ADAPTIX, Inc., net of cash acquired (150,000) 0 0
Patent acquisition costs (178,260) (14,680) (8,224)
Net cash used in investing activities (408,792) (23,237) (8,098)
Cash flows from financing activities:      
Proceeds from sale of common stock, net of issuance costs 218,961 175,229 0
Repurchases of common stock (26,732) 0 0
Distributions to noncontrolling interests in operating subsidiary (312) (2,897) (4,807)
Contributions from noncontrolling interests in operating subsidiary, net of issuance costs 5,793 1,539 2,393
Proceeds from the exercise of stock options 340 411 15,068
Excess tax benefits from stock-based compensation 13,210 583 1,302
Net cash provided by financing activities 211,260 174,865 13,956
Increase in cash and cash equivalents (92,929) 212,218 50,780
Cash and cash equivalents, beginning 314,733 102,515 51,735
Cash and cash equivalents, ending $ 221,804 $ 314,733 $ 102,515